Cyclophosphamide
HPV Positive Rectal Squamous Cell Carcinoma
Christian HinrichsSmall moleculePhase 2Active
CCC
53/ 100
Provisional rating · Methodology v0.2
Rating breakdown
- Clinical Evidence
- 38/ 100
- Competitive Position
- 89/ 100
Competitive context
9 Active assets in the HPV Positive Rectal Squamous Cell Carcinoma cohort.
| Asset / Sponsor | Phase | Rating |
|---|---|---|
e7 tcr-t cells Christian Hinrichs | Phase 2 | CCC |
Fludarabine Christian Hinrichs | Phase 2 | CCC |
Tsc-204-A0101 TScan Therapeutics, Inc. | Phase 1 | CC |
Tsc-204-A0201 TScan Therapeutics, Inc. | Phase 1 | CC |
Tsc-201-B0702 TScan Therapeutics, Inc. | Phase 1 | CC |
View all 9 →
Same molecule, other indications
Cyclophosphamide is also rated in:
Are you the sponsor?
Submit your data room for a Verified Rating. The public-data rating remains visible alongside.
Contact →